Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ligand Pharmaceuticals (LGNYZ) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Ligand Pharmaceuticals (LGNYZ) over the last 12 years, with Q3 2025 value amounting to 0.3.

  • Ligand Pharmaceuticals' Debt Ratio changed N/A to 0.3 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3, marking a year-over-year change of. This contributed to the annual value of 0.1 for FY2022, which is N/A changed from last year.
  • Latest data reveals that Ligand Pharmaceuticals reported Debt Ratio of 0.3 as of Q3 2025.
  • Ligand Pharmaceuticals' 5-year Debt Ratio high stood at 0.3 for Q3 2025, and its period low was 0.07 during Q3 2022.
  • Over the past 3 years, Ligand Pharmaceuticals' median Debt Ratio value was 0.1 (recorded in 2022), while the average stood at 0.14.